Chase AIPricingFAQs
Display currency
Loading news…

Isomorphic Labs

ActiveOperating status — whether the company still runs independently. “Closed” usually means it was acquired, merged, or shut down.🔥 HighHeat score — how much recent activity & attention the company has (web traffic, news, hiring).📈 High growthGrowth score — momentum trend across web traffic, headcount and other growth signals.
London, England, United Kingdom Founded 2021 251-500 employees For Profit

Isomorphic Labs is an AI-first drug design and development company that transforms drug discovery to design and evaluate new medicines.

Total Funding
Available in Pro
Last Funding
Available in Pro
Acquisitions
0
Monthly Visits
Available in Pro
Contacts
30
Patents
12
14 trademarks

Company Details

Funding & Financials

Pro
Total funding
Funding rounds
Last funding
Last funding type
Last funding date
Funding status
Total equity funding
Revenue range

IPO & Stock

IPO status
Private

Web Traffic

Pro
Monthly visits
Global traffic rank
6-mo avg visits
Visit duration (s)
Pages / visit
Bounce rate
Rank change (mo)

Technology & IP

Active technologies
2
Patents granted
12
Trademarks
14
IT spend
$192K

Company Info

Founded
2021
Employees
251-500
Operating status
Active
Company type
For Profit
Org types
company
Founders
1
News articles
258
HQ
London, England, United Kingdom
Region
Europe, Middle East, and Africa (EMEA)

Signals & Scores

Heat score
High
Growth score
High
Trend (7d)
-0.5
Trend (30d)
-4.9
Trend (90d)
5.5
Last leadership hire
Jun 17, 2025

Key People at Isomorphic Labs

Senior Research Leader
Chief Technology Officer
30
professional contacts at Isomorphic Labs
Contact execs at Isomorphic Labs

Explore 200,000+ acquisitions — free

Filter the full database across sectors, companies, dates, and deal sizes. No signup, no paywall.

Explore all acquisitions

Recent News related to Isomorphic Labs

Loading news…

FAQs about Isomorphic Labs

People who checked this page also checked these

Browse the full Acquirezy directory.
Isomorphic Labs - Company Profile, Full Acquisitions List, Funding and Investments